Bleomycin
Cold Chain RequiredFDA Approved, EMA Approved
Description
Bleomycin is a glycopeptide antibiotic with antineoplastic activity used in combination chemotherapy regimens. It is commonly used in the treatment of germ cell tumors including malignant ovarian germ cell neoplasms as part of the BEP (bleomycin, etoposide, cisplatin) regimen. Bleomycin causes DNA strand breaks and inhibits DNA synthesis.
Indications & Therapeutic Use
Malignant ovarian germ cell neoplasm, testicular cancer, Hodgkin lymphoma, squamous cell carcinoma
Linked Diseases:
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Bleomycin
| Generic Name | Bleomycin |
| Brands | 1 brand available |
| Active Ingredient | Bleomycin sulfate |
| Drug Class | Malignant ovarian germ cell neoplasm |
| Manufacturer | Various |
| Dosage Forms | IV/IM/SC injection, 15 units and 30 units vials |
| Medical Code | L01DC01 |
| Orphan Status | No |
| Cold Chain | Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved, EMA Approved |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes